Want to see HK:2158 full AI Analyst Report?
2158 Stock Chart & Stats
HK$5.58
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$5.58
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$3.69 - HK$7.22
Previous CloseN/A
Volume5.15M
Average Volume (3M)6.36M
Market Cap
HK$4.23B
Enterprise ValueHK$3.05K
Total Cash (Recent Filing)HK$2.22B
Total Debt (Recent Filing)HK$71.09M
Price to Earnings (P/E)51.6
Beta1.73
Next Earnings
Nov 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.01%
Share Statistics
EPS (TTM)0.07
Shares Outstanding1,072,892,200
10 Day Avg. Volume7,880,599
30 Day Avg. Volume6,357,449
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)1.25
Price to Sales (P/S)5.73
P/FCF Ratio-87.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$6.80Price Target Upside21.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.05
Revenue Forecast (FY)HK$972.31M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage limits refinancing and solvency risk, preserving financial flexibility for continued investment in healthcare data and AI platforms while reducing the likelihood that debt obligations constrain operations during periods of uneven profitability.
Return To ProfitabilityThe swing from heavy losses in 2021–2024 to positive net income indicates improving financial performance and may support further investment. If sustained, profitability could strengthen the company’s ability to scale its data and clinical technology offerings.
Improved Cash GenerationPositive operating and free cash flow, together with strong free-cash-flow conversion in 2026, improves earnings quality and reduces reliance on external funding. This provides a better base for developing platforms and serving pharmaceutical and hospital customers.
Bears Say
Negative Core Operating ProfitPositive net income is not yet supported by sustained operating earnings power. Continued negative operating profit and EBITDA suggest the core business may still lack sufficient scale, pricing strength, or cost discipline to produce durable profitability.
Volatile Cash ProfileSeveral years of sizable cash burn reduce confidence that the latest cash improvement is durable. The history indicates that project timing, customer demand, or investment needs can materially affect liquidity, making future self-funded growth less predictable.
Uneven Revenue And Capital EfficiencyChoppy revenue performance points to inconsistent demand or execution, while weak historical shareholder returns indicate low capital efficiency. These issues could limit the benefits of the company’s healthcare technology opportunity unless growth becomes more consistent.
Yidu Tech, Inc. News
2158 FAQ
What was Yidu Tech, Inc.’s price range in the past 12 months?
Yidu Tech, Inc. lowest stock price was HK$3.69 and its highest was HK$7.22 in the past 12 months.
What is Yidu Tech, Inc.’s market cap?
Yidu Tech, Inc.’s market cap is HK$4.23B.
When is Yidu Tech, Inc.’s upcoming earnings report date?
Yidu Tech, Inc.’s upcoming earnings report date is Nov 20, 2026 which is in 74 days.
How were Yidu Tech, Inc.’s earnings last quarter?
Yidu Tech, Inc. released its earnings results on Jun 29, 2026. The company reported HK$0.093 earnings per share for the quarter.
Is Yidu Tech, Inc. overvalued?
According to Wall Street analysts Yidu Tech, Inc.’s price is currently Undervalued.
Does Yidu Tech, Inc. pay dividends?
Yidu Tech, Inc. pays a Notavailable dividend of HK$0.04 which represents an annual dividend yield of 1.01%. See more information on Yidu Tech, Inc. dividends here
What is Yidu Tech, Inc.’s EPS estimate?
Yidu Tech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yidu Tech, Inc. have?
Yidu Tech, Inc. has 1,072,892,200 shares outstanding.
What happened to Yidu Tech, Inc.’s price movement after its last earnings report?
Yidu Tech, Inc. reported an EPS of HK$0.093 in its last earnings report. Following the earnings report the stock price went up 6.421%.
Which hedge fund is a major shareholder of Yidu Tech, Inc.?
Currently, no hedge funds are holding shares in HK:2158
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yidu Tech, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.03%
12-Months-Change
Fundamentals
Return on Equity
1.01%
Trailing 12-Months
Asset Growth
-2.66%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Yidu Tech, Inc.
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
2158 Stock 12 Month Forecast
Average Price Target
HK$6.80
▲(21.86% Upside)
Technical Analysis
Ping An Healthcare and Technology Company
―
Kindstar Globalgene Technology, Inc.
―
Medlive Technology Co., Ltd.
―
NEUSOFT XIKANG HOLDINGS INC.
―
Xunfei Healthcare Technology Co., Ltd.
―